News, Short Squeeze, Breakout and More Instantly...
2024-07-02 08:30:06 ET Jefferies analyst issues BUY recommendation for GSK on July 2, 2024 06:21AM ET. The previous analyst recommendation was Buy. GSK was trading at $38.38 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst ...
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes 1 Clinical development program continues to evaluate safety and immunogenicity in adults 18+ with data read-outs expected H2 2024 GSK plc (LSE/NYSE: GSK) today an...
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response New treatment options are needed for patients facing negative impacts to quality-of-life with current standard of care Additional registrational ...